RUNX1 and acute lymphoblastic leukemia: The next most commonly reported gene alterations in ALL derived from T cell patients were FBXW7 (8–30%), PHF6 (20%), PTEN (20%), WT1 (15%), RUNX1 (10–20%), LEF1 (10–15%), and ETV6 (5–15%).